March 4, 2019 | Vensana in the News

Medical Device Investors Form New Medtech Venture Firm

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

32

Exits by IPO or M&A